CeBIL - Centre for Advanced Studies in Biomedical Innovation Law

News from CeBIL

Making biosimilars more accessible by solving legal and regulatory challenges

2020.11.15

A study conducted at the Department of Pharmacy, and published in the prestigious journal Nature Biotechnology, shows that while knowledge about biosimilars is expanding, their access to the market is limited by legal and regulatory challenges that remains to be addressed.
CeBIL Director Timo Minssen appointed as Acting Chair of International AMR Social Science Network

2020.10.26

Professor Timo Minssen has been appointed as Acting-Chair of and international expert network studying social science aspects of antimicrobial resistance.
New publication on Navigating Cross-Border Transfers in the Pharma Sector After Schrems

2020.10.13

…
Timo Minssen, Helen Yu & Sven Bostyn from CeBIL talk in Intellectual Property Management Workshop at WIPO

2020.10.13

…
CeBIL Director Timo Minssen talks in panel debate at Harvard/MIT Global Conference on Regulatory Science 2020

2020.10.13

…
New publication on Financial Incentives for Unimpressive New Antibiotics

2020.09.23

…
CeBIL Director Professor Timo Minssen presents at the 4th Biocom AMR Conference

2020.08.18

…
Annika Frida Petersen – New Postdoc

2020.06.30

…
New book chapter on Ethical and Legal Challenges of Artificial Intelligence-Driven Health Care

2020.06.25

…
New publication on European artificial intelligence strategy: implications and challenges for digital health

2020.06.24

…